Imatinib-induced extensive hyperpigmentation in a case of chronic myeloid leukemia

Indian Journal of Dermatology

关键词: Hyperpigmentation;    Imatinib;    leukemia;   

DOI  :  10.4103/0019-5154.164447

来源: DOAJ

【 摘 要 】

Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.

【 授权许可】

Unknown